BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28063963)

  • 1. Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia.
    Levinson A; Arnold S; Jin Z; Bhatia M; George D; Garvin JH; Satwani P
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):696-700. PubMed ID: 28063963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?
    Curley C; Durrant S; Kennedy GA
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
    Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
    Lee JH; Choi SJ; Lee JH; Seol M; Lee YS; Ryu SG; Park CJ; Chi HS; Lee MS; Yun S; Lee JS; Lee KH
    Haematologica; 2005 Oct; 90(10):1380-8. PubMed ID: 16219575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.
    Oshima K; Kanda Y; Yamashita T; Takahashi S; Mori T; Nakaseko C; Fujimaki K; Yokota A; Fujisawa S; Matsushima T; Fujita H; Sakura T; Okamoto S; Maruta A; Sakamaki H;
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1100-1107. PubMed ID: 18804039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.
    Solh M; DeFor TE; Weisdorf DJ; Kaufman DS
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.
    Solomon SR; Sizemore CA; Zhang X; Brown S; Holland HK; Morris LE; Solh M; Bashey A
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1816-1822. PubMed ID: 27453362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].
    Imanaka R; Katayama Y; Iwato K; Kyo K; Okatani T; Itagaki M; Katsutani S; Asaoku H
    Rinsho Ketsueki; 2018; 59(1):58-63. PubMed ID: 29415939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of routine bone marrow examination in pediatric acute myeloid leukemia (AML): a study of the Dutch Childhood Oncology Group (DCOG).
    Hageman IM; Peek AM; de Haas V; Damen-Korbijn CM; Kaspers GJ
    Pediatr Blood Cancer; 2012 Dec; 59(7):1239-44. PubMed ID: 22378688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.
    Rubin J; Vettenranta K; Vettenranta J; Bierings M; Abrahamsson J; Békássy AN; Håkansson Y; Frost BM; Arvidson J; Spendilow C; Winiarski J; Gustafsson B
    Bone Marrow Transplant; 2011 Mar; 46(3):372-8. PubMed ID: 20498650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.
    Chen GL; Liu H; Zhang Y; Thomas J; Ross M; Wang ES; Block AW; Sait S; Deeb G; Wallace P; Wetzler M; Hahn T; McCarthy PL
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1369-74. PubMed ID: 24867777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.
    Fuerst D; Mueller C; Beelen DW; Neuchel C; Tsamadou C; Schrezenmeier H; Mytilineos J
    Haematologica; 2016 Feb; 101(2):241-7. PubMed ID: 26611475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.